328 related articles for article (PubMed ID: 17409991)
1. Proteomic strategies for the characterization and the early detection of lung cancer.
Massion PP; Caprioli RM
J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991
[TBL] [Abstract][Full Text] [Related]
2. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J
J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301
[TBL] [Abstract][Full Text] [Related]
3. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
4. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
Hirano T; Kato H
Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
[TBL] [Abstract][Full Text] [Related]
5. [Application of proteomics to diagnosis and treatment of lung cancer].
Dai M; Luo RC
Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
[TBL] [Abstract][Full Text] [Related]
6. Proteomics in gastrointestinal cancer.
Ebert MP; Yu J; Lordick F; Röcken C
Ann Oncol; 2006 Sep; 17 Suppl 10():x253-8. PubMed ID: 17018734
[No Abstract] [Full Text] [Related]
7. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer.
Fels LM; Buschmann T; Meuer J; Reymond MA; Lamer S; Röcken C; Ebert MP
Dig Dis; 2003; 21(4):292-8. PubMed ID: 14752218
[TBL] [Abstract][Full Text] [Related]
8. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
9. Identification of β-tubulin as a common immunogen in gastrointestinal malignancy by mass spectrometry of colorectal cancer proteome: implications for early disease detection.
Bouras G; Nakanishi T; Fujita Y; Tsunemi S; Takubo T; Tanigawa N
Anal Bioanal Chem; 2012 Jun; 403(7):1801-9. PubMed ID: 22271099
[No Abstract] [Full Text] [Related]
10. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
[TBL] [Abstract][Full Text] [Related]
11. Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
Solassol J; Du-Thanh A; Maudelonde T; Guillot B
Int J Biol Markers; 2011; 26(2):82-7. PubMed ID: 21607923
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.
Indovina P; Marcelli E; Pentimalli F; Tanganelli P; Tarro G; Giordano A
Mass Spectrom Rev; 2013; 32(2):129-42. PubMed ID: 22829143
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract][Full Text] [Related]
14. Translational Research and Plasma Proteomic in Cancer.
Santini AC; Giovane G; Auletta A; Di Carlo A; Fiorelli A; Cito L; Astarita C; Giordano A; Alfano R; Feola A; Di Domenico M
J Cell Biochem; 2016 Apr; 117(4):828-35. PubMed ID: 26479787
[TBL] [Abstract][Full Text] [Related]
15. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
16. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
[TBL] [Abstract][Full Text] [Related]
18. Reduced transthyretin expression in sera of lung cancer.
Liu L; Liu J; Dai S; Wang X; Wu S; Wang J; Huang L; Xiao X; He D
Cancer Sci; 2007 Oct; 98(10):1617-24. PubMed ID: 17683510
[TBL] [Abstract][Full Text] [Related]
19. [Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people].
Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Yang DC; He DC
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):31-4. PubMed ID: 16638298
[TBL] [Abstract][Full Text] [Related]
20. An introduction into proteomics and its clinical applications.
Ahram M
Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]